Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

5 stocks to buy with £20k in a Stocks and Shares ISA

Rupert Hargreaves looks at five stocks he’d buy today for his Stocks and Shares ISA with £20,000 and a long-term outlook.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Using a Stocks and Shares ISA is one of the best ways to invest in the market. Any income or capital gains earned on assets held within one of these wrappers doesn’t attract any further tax. Investors don’t even need to declare the income on their tax returns.

I try to make the most of my £20k ISA allowance every year as soon as possible. Here are five stocks I’d buy with my latest allowance today.

Stocks and Shares ISA

Thanks to the tax benefits of an ISA, I think they’re the perfect wrappers in which to own income investments.

I’d buy FTSE 100 healthcare stocks Hikma and GlaxoSmithKline with a portion of my £20,000 investment on this theme. 

Hikma manufactures a range of generic, low-cost medications. Meanwhile, Glaxo is more of a healthcare conglomerate, with treatments spanning from vaccines to oncology and an extensive consumer healthcare portfolio. This mixture provides healthy cash flows to support the firm’s large dividend yield of 5.6%. 

Hikma is more of a dividend growth investment. The stock offers a dividend yield of 1.5%, at the time of writing. Over the past five years, as the company’s earnings have expanded, its per-share dividend has grown at a compound annual rate of nearly 10%. As such, over the long term, I think this could be a fantastic income investment. 

Of course, these assets aren’t risk-free. Dividends are paid out of profits, and if the income at Glaxo or Hikma falls, the payouts could be slashed. Any number of factors could lead to this outcome. A sudden unforeseen economic downturn, legal battle, or higher than expected costs could significantly reduce earnings power. 

Despite these risks, I’d buy Glaxo and Hikma for my Stocks and Shares ISA portfolio today. 

Steady income 

Two other income plays I’d buy are Assura and Airtel Africa. Assura owns medical facilities in the UK, which it leases to healthcare providers. Airtel owns mobile phone towers across Africa.

The stocks offer dividend yields of 3.7% and 4.9% respectively. These payouts aren’t guaranteed. Both companies also use a lot of debt to fund their operations, which could limit their ability to grow the distributions in the long run. 

Still, I’d buy the equities for my Stocks and Shares ISA due to their cash flows from stable infrastructure assets. 

Growth investment 

The final company I’d buy for my £20,000 portfolio is a growth investment. Spirent Communications develops technology for the communications industry, in particular equipment used in 5G networks.

The 5G global services market is expected to grow at a compound annual growth rate of 46.2% from 2021 to 2028. I think if Spirent can grab just a tiny share of this market, it could be an excellent growth investment. 

The main challenge the business faces is standing out in such a competitive market. The market may also not live up to growth expectations. This could mean Spirent’s long-term growth is lower than expected. 

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has recommended GlaxoSmithKline and Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Up 30% in 2025 and still cheap! Is this former stock market darling the best share to buy today?

Harvey Jones has been hunting for the best shares to buy for his SIPP, and found what he thinks is…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

£5,000 to invest? Consider 5 no-brainer dividend shares with over 20 years of growth

These UK dividend shares have some of the longest track records of consistent growth, making them a dream for passive…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

How to build passive income starting with just £3 a day

Starting with only £3 a day, it's possible to build a pot worth £200,000 over decades. But which investments does…

Read more »

Investing Articles

£5,000 invested in Tesco shares at the start of 2025 is now worth…

Tesco shares have enjoyed a very strong run over the past couple of years. But where next for this FTSE…

Read more »

Night Takeoff Of The American Space Shuttle
Investing Articles

4 dirt-cheap growth shares to consider for 2026!

Discover four top growth shares that could take off in the New Year -- and why our writer Royston Wild…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

I asked ChatGPT how to start investing in UK shares with just £500 and it said do this

Harvey Jones asks artificial intelligence a few questions about how to get started in investing, before giving up and deciding…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Dividend Shares

Yielding 10.41%, is this the best dividend share in the FTSE 250?

Jon Smith points out a dividend share with a double-digit yield, but explains why digging below the surface provides important…

Read more »

Investing Articles

Is 2026 the year it all goes wrong for the Rolls-Royce share price?

2025 has been another stellar year for the Rolls-Royce share price but Harvey Jones wonders just how long its magnificent…

Read more »